Related Experiment Video
Updated: Dec 21, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
iPiDi-PUL: identifying Piwi-interacting RNA-disease associations based on positive unlabeled learning
Abstract:
Accumulated researches have revealed that Piwi-interacting RNAs (piRNAs) are regulating the development of germ and stem cells, and they are closely associated with the progression of many diseases. As the number of the detected piRNAs is increasing rapidly, it is important to computationally identify new piRNA-disease associations with low cost and provide candidate piRNA targets for disease treatment. However, it is a challenging problem to learn effective association patterns from the positive piRNA-disease associations and the large amount of unknown piRNA-disease pairs. In this study, we proposed a computational predictor called iPiDi-PUL to identify the piRNA-disease associations. iPiDi-PUL extracted the features of piRNA-disease associations from three biological data sources, including piRNA sequence information, disease semantic terms and the available piRNA-disease association network. Principal component analysis (PCA) was then performed on these features to extract the key features. The training datasets were constructed based on known positive associations and the negative associations selected from the unknown pairs. Various random forest classifiers trained with these different training sets were merged to give the predictive results via an ensemble learning approach. Finally, the web server of iPiDi-PUL was established at http://bliulab.net/iPiDi-PUL to help the researchers to explore the associated diseases for newly discovered piRNAs.
Related Concept Videos
piRNA - Piwi-interacting RNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi

